Merge Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Merge Therapeutics General Information
Description
Operator of a biotechnology company intended to accelerate therapeutic research and development. The company develops dual-depleting macrophage engager antibodies for the treatment of immune-mediated diseases, enabling medical professionals to improve the lives of patients who live with autoimmune and chronic inflammatory diseases.
Contact Information
Website
mergetx.comCorporate Office
- 108 Morning Sun Avenue
- Mill Valley, CA 94941
- United States
Corporate Office
- 108 Morning Sun Avenue
- Mill Valley, CA 94941
- United States
Merge Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 16-Jun-2025 | Completed | Startup | |||
| 2. Early Stage VC | 01-Jan-2025 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2025 | Completed | Startup |
Merge Therapeutics Patents
Merge Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026073139-A1 | Bispecific antibodies and methods of use thereof | Pending | 30-Sep-2024 |
Merge Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| Mission BioCapital | Venture Capital | Minority | ||
| Roche Venture Fund | Corporate Venture Capital | Minority | ||
| Termeer Institute | Accelerator/Incubator |
Merge Therapeutics FAQs
-
When was Merge Therapeutics founded?
Merge Therapeutics was founded in 2024.
-
Where is Merge Therapeutics headquartered?
Merge Therapeutics is headquartered in Mill Valley, CA.
-
What industry is Merge Therapeutics in?
Merge Therapeutics’s primary industry is Drug Discovery.
-
Is Merge Therapeutics a private or public company?
Merge Therapeutics is a Private company.
-
What is Merge Therapeutics’s current revenue?
The current revenue for Merge Therapeutics is .
-
Who are Merge Therapeutics’s investors?
Johnson & Johnson Innovation - JLABS, Mission BioCapital, Roche Venture Fund, and Termeer Institute have invested in Merge Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process